Jonathan H. Kaufman 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 5:00 pm Purchase | 2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,294 16.200% | 11,250 (+5.60%) | Filing |
| 2024-05-06 4:05 pm Sale | 2024-05-02 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 201,044 19.300% | -3,333 (-1.63%) | Filing |
| 2024-03-19 4:10 pm Purchase | 2024-03-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 204,377 21.000% | 16,875 (+9.00%) | Filing |
| 2024-03-15 12:13 pm Purchase | 2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 187,502 19.500% | 18,113 (+10.69%) | Filing |
| 2024-03-06 5:05 pm Purchase | 2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 169,389 18.300% | 10,833 (+6.83%) | Filing |
| 2023-06-21 5:05 pm Purchase | 2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 158,555 20.100% | 14,104 (+9.76%) | Filing |
| 2022-12-29 5:20 pm Purchase | 2022-12-19 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 144,451 18.600% | 144,451 (New Position) | Filing |